SlideShare a Scribd company logo
Approach to the Patient
with an Infectious Disease
Dr. Krishn Undaviya
Infectious Disease
• Annually, 15% of all deaths worldwide are directly attributable to infectious
diseases.
• Infectious diseases remain the second leading cause of death worldwide.
• Although the rate of infectious disease–related deaths has decreased dramatically over the
past 25 years .
WHEN TO OBTAIN AN INFECTIOUS DISEASE
CONSULT
• Specific situations that might prompt a consult include
• (1) difficult-to-diagnose patients with presumed infections,
• (2) patients who are not responding to treatment as expected,
• (3) patients with a complicated medical history (e.g., organ transplant recipients,
patients immunosuppressed due to auto- immune or inflammatory conditions), and
• (4) patients with “exotic” diseases (i.e., diseases that are not typically seen within the
region).
History
1. Exposure History
2. Social History
3. Dietary habits
4. Animal exposure
5. Travel history
6. Host specific factors
• These aspects focus on two areas:
• (1) an exposure history that may identify microorganisms with which the patient may have
come into contact and
• (2) host-specific factors that may predispose to the development of an infection.
Exposure History
• History of infections or exposure to drug-resistant microbes
• Whether a patient has a history of infection with drug- resistant organisms (e.g., methicillin-
resistant S. aureus, vancomycin- resistant Enterococcus species, enteric organisms that
produce an extended-spectrum β-lactamase or carbapenemase) or
• May have been exposed to drug-resistant microbes (e.g., during a recent stay in a
hospital, nursing home, or long-term acute-care facility) may alter the choice of empirical
antibiotics.
• For example, a patient presenting with sepsis who is known to have a history of invasive
infection with a multidrug-resistant isolate of P. aeruginosa should be treated empirically
with an antimicrobial regimen that will cover this strain. (penicillin or Cephalosporin)
Social History
• High- risk behaviors (e.g., unsafe sexual behaviors, intravenous [IV] drug use)
• Potential hobby-associated exposures (e.g., avid gardening, with possible Sporothrix
schenckii exposure)
• Occupational exposures (e.g., increased risk for M. tuberculosis exposure in funeral
service workers)
Dietary habits
• Shiga toxin–producing strains of Escherichia coli, and Toxoplasma gondii are associated
with the consumption of raw or undercooked meat
• Salmonella typhimurium, Listeria monocytogenes, and Mycobacterium bovis with
unpasteurized milk
• Leptospira species, parasites, and enteric bacteria with unpurified water
• Vibrio species, norovirus, helminths, and protozoa with raw seafood.
Animal exposure
• Dogs: Lyme disease, Rocky Mountain spotted fever, and ehrlichiosis
• Cats: Bartonella henselae infection
• Reptiles: Salmonella infection
• Rodents: leptospirosis
• Rabbits: tularemia
Travel history
• H/o international or domestic travel
• What kinds of activities and behaviors the patient engaged in during travel (e.g., the types
of food and sources of water consumed, freshwater swimming, animal exposures)
• Whether the patient had the necessary immunizations and/or took the necessary
prophylactic medications prior to travel;
Host specific factors
• Many opportunistic infections (e.g., with Pneumocystis jirovecii, Aspergillus species, or JC
virus) affect primarily immunocompromised patients
• Defects in the immune system may be due to:
• an underlying disease (e.g., malignancy, HIV infection, malnutrition),
• a medication (e.g., chemotherapy, glucocorticoids, monoclonal antibodies to
components of the immune system),
• a treatment modality (e.g., total body irradiation, splenectomy),
• or a primary immunodeficiency.
General Examination
• Vital signs
• Lymphatics
• Wbc count
• Inflammatory marker
• CSF
• Skin
• Culture
• Radiology
Vital signs
• Elevations in temperature are often a hallmark of infection
• Paying close attention to the temperature may be of value in diagnosing an infectious
disease.
• For every 1°C (1.8°F) increase in core temperature, the heart rate typically rises by 15–20
beats/min.
• Although this pulse–temperature dissociation is not highly sensitive or specific for
establishing a diagnosis, it is potentially useful in low-resource settings given its ready
availability and simplicity.
Skin
• It is important to perform a complete skin exam, with attention to both front and back.
• In numerous anecdotal instances, patients in the intensive care unit have had “fever of
unknown origin” that was actually due to unrecognized pressure ulcers.
• Moreover, close examination of the distal extremities for splinter hemorrhages, Janeway
lesions, or Osler’s nodes may yield evidence of endocarditis or other causes of septic
emboli.
Foreign Body
• As previously mentioned, many infections are caused by members of the indigenous microbiota.
• These infections typically occur when these microbes escape their normal habitat and enter a
new one.
• Thus, maintenance of epithelial barriers is one of the most important mechanisms in
protection against infection.
• However, hospitalization of patients is often associated with breaches of these barriers—e.g.,
due to placement of IV lines, surgical drains, or tubes (e.g., endotracheal tubes and Foley
cathe- ters) that allow microorganisms to localize in sites to which they normally would not have
access
• Accordingly, knowing what lines, tubes, and drains are in place is helpful in ascertaining what
body sites might be infected.
Diagnostic Testing
• Laboratory and radiologic testing has advanced greatly over the past few decades and has
become an important component in the evaluation of patients.
• The dramatic increase in the number of serologic diagnostics, antigen tests, and
molecular diagnostics available to the physician has, in fact, revolutionized medical care.
• However, all of these tests should be viewed as adjuncts to the history and physical
examination—not a replacement for them.
WBC Count
• Elevations in the WBC count are often associated with infection,
• though many viral infections are associated with leukopenia. Like influenza, HIV,
hepatitis, autoimmune conditions like RA, lupus, Sjogren, Hodgkins lymphoma,
Myelofibrosis.
• it is important to assess the WBC differential, given that different classes of microbes are
associated with various leukocyte types :
• Bacteria: polymorphonuclear neutrophils
• Virus: lymphocytes
• Parasites: eosinophills
Inflammatory marker
• ESR & CRP
• ESR: Indirect measure of acute phase response
• CRP: Direct measure of acute phase response
• used to assess a patient’s general level of inflammation.
• ESR changes relatively slowly, and its measurement more often than weekly usually is not
useful; in contrast, CRP concentrations change rapidly, and daily measurements can be
useful in the appropriate context.
• An extremely elevated ESR (>100 mm/h) has a 90% predictive value for a serious
underlying disease
CSF
• Assessment of CSF is critical for patients with suspected meningitis or encephalitis.
• An opening pressure should always be recorded, and fluid should routinely be sent for cell
counts, Gram’s stain and culture, and determination of glucose and protein levels.
• A CSF Gram’s stain typically requires >105 bacteria/mL for reliable positivity; its specificity
approaches 100%.
Cultures
• The mainstays of infectious disease diagnosis include the culture of infected tissue (e.g.,
surgical specimens) or fluid (e.g., blood, urine, sputum, pus from a wound).
• Samples can be sent for culture of bacteria (aerobic or anaerobic), fungi, or viruses.
Ideally, specimens are collected before the administration of antimicrobial therapy
• in instances where this order of events is not clinically feasible, microscopic examination
of the specimen (e.g., Gram- stained or potassium hydroxide [KOH]–treated preparations)
is particularly important.
Pathogen Specific Testing
• For organism that are not easily cultivable
• Serology
• Antigen testing
• PCR testing
Radiology
• Imaging provides an important adjunct to the physical examination, allowing evaluation for
lymphadenopathy in regions that are not externally accessible (e.g., mediastinum,
intraabdominal sites).
• Assessment of internal organs for evidence of infection, and facilitation of image-guided
percutaneous sampling of deep spaces.
• The choice of imaging modality (e.g., CT, MRI, ultrasound, nuclear medicine, use of
contrast) is best made in consultation with a radiologist to ensure that the results will
address the physician’s specific concerns.
Treatment
• We should balance the need for empirical antibiotic treatment with the patient’s clinical
condition.
• When clinically feasible, it is best to obtain relevant samples (e.g., blood, CSF, tissue,
purulent exudate) for culture prior to the administration of antibiotics, as antibiotic
treatment often makes subsequent diagnosis more difficult.
• Although a general maxim for antibiotic treatment is to use a regimen with as narrow a
spectrum as possible, empirical regimens are necessarily somewhat broad, given that a
specific diagnosis has not yet been made.
• These regimens should be narrowed as appropriate once a specific diagnosis is made.
• The study of infectious diseases is really a study of host–microbial interactions and
represents evolution by both the host and the microbe—an endless struggle in which
microbes have generally been more creative and adaptive.
• Given that nearly one-fifth of deaths worldwide are still related to infectious diseases, it is
clear that the war against infectious diseases has not been won. For example, a cure for
HIV infection is still lacking, there have been only marginal improvements in the methods
for detection and treatment of tuberculosis after more than a half century of research, new
infectious disease outbreaks (e.g., viral hemorrhagic fevers, Zika, SARS-CoV-2) continue
to emerge, and the threat of microbial bioterrorism remains high.
• Despite numerous advances in the diagnosis, treatment, and prevention of
infectious diseases, much work and research are required before anyone can
confidently claim we have achieved “the virtual elimination of infectious disease.”
• In reality, this goal will never be attained, given the rapid adaptability of microbes.

More Related Content

What's hot

Caroli syndrome
Caroli syndrome Caroli syndrome
Caroli syndrome
Ahmed Ghany
 
Acute appendicitis
Acute appendicitisAcute appendicitis
Acute appendicitis
مرتضى جواد
 
Gallbladder, The Big Picture
Gallbladder, The Big PictureGallbladder, The Big Picture
Gallbladder, The Big Picture
Оладапо Олувабукола
 
Disorders of gall bladder
Disorders of gall bladderDisorders of gall bladder
Disorders of gall bladder
norhidayahabubakar
 
Chronic Hepatitis
Chronic HepatitisChronic Hepatitis
Chronic Hepatitis
Eneutron
 
Treatment of lymphadenitis
Treatment  of lymphadenitisTreatment  of lymphadenitis
Treatment of lymphadenitis
Rishi Kashyap
 
Obstructive jaundice
Obstructive jaundiceObstructive jaundice
Obstructive jaundice
Chinamilli Jaahnavi
 
Abdominal tb
Abdominal tbAbdominal tb
Abdominal tb
Dr. MD. Majedul Islam
 
intetinal tuberculosis
intetinal tuberculosisintetinal tuberculosis
intetinal tuberculosis
Sadia Shabbir
 
Acute cholecystitis
Acute cholecystitisAcute cholecystitis
Acute cholecystitis
AzriAmirullah
 
Intussusception by Dr.AmrithaAnilkumar
Intussusception by Dr.AmrithaAnilkumarIntussusception by Dr.AmrithaAnilkumar
Intussusception by Dr.AmrithaAnilkumar
Dr. Amritha Anilkumar
 
Hernias - a Brief Med Students Guide
Hernias - a Brief Med Students GuideHernias - a Brief Med Students Guide
Hernias - a Brief Med Students Guide
meducationdotnet
 
what is jaundice ? causes ? types ? surgical treatment
what is jaundice ? causes ? types ? surgical treatmentwhat is jaundice ? causes ? types ? surgical treatment
what is jaundice ? causes ? types ? surgical treatment
aws aliraqi
 
TUMORS OF LOWER URINARY TRACT
TUMORS OF LOWER URINARY TRACT TUMORS OF LOWER URINARY TRACT
TUMORS OF LOWER URINARY TRACT
Dr. Roopam Jain
 
Pancretitis
PancretitisPancretitis
Pancretitis
Faiz Hmoud
 
GI Bleeding (Upper and Lower GIB)
GI Bleeding (Upper and Lower GIB)GI Bleeding (Upper and Lower GIB)
GI Bleeding (Upper and Lower GIB)
Chy Yong
 
Rectal prolapse
Rectal prolapseRectal prolapse
Rectal prolapse
Dr.S.K.Jain Surgical Team
 
Immunological mechanism of kidney injury
Immunological mechanism of kidney injuryImmunological mechanism of kidney injury
Immunological mechanism of kidney injury
Dr. Taraknath Chatterjee
 
Achalasia
AchalasiaAchalasia
Achalasia
Ayub Abdi
 
Appendicitis
AppendicitisAppendicitis
Appendicitis
Nandinii Ramasenderan
 

What's hot (20)

Caroli syndrome
Caroli syndrome Caroli syndrome
Caroli syndrome
 
Acute appendicitis
Acute appendicitisAcute appendicitis
Acute appendicitis
 
Gallbladder, The Big Picture
Gallbladder, The Big PictureGallbladder, The Big Picture
Gallbladder, The Big Picture
 
Disorders of gall bladder
Disorders of gall bladderDisorders of gall bladder
Disorders of gall bladder
 
Chronic Hepatitis
Chronic HepatitisChronic Hepatitis
Chronic Hepatitis
 
Treatment of lymphadenitis
Treatment  of lymphadenitisTreatment  of lymphadenitis
Treatment of lymphadenitis
 
Obstructive jaundice
Obstructive jaundiceObstructive jaundice
Obstructive jaundice
 
Abdominal tb
Abdominal tbAbdominal tb
Abdominal tb
 
intetinal tuberculosis
intetinal tuberculosisintetinal tuberculosis
intetinal tuberculosis
 
Acute cholecystitis
Acute cholecystitisAcute cholecystitis
Acute cholecystitis
 
Intussusception by Dr.AmrithaAnilkumar
Intussusception by Dr.AmrithaAnilkumarIntussusception by Dr.AmrithaAnilkumar
Intussusception by Dr.AmrithaAnilkumar
 
Hernias - a Brief Med Students Guide
Hernias - a Brief Med Students GuideHernias - a Brief Med Students Guide
Hernias - a Brief Med Students Guide
 
what is jaundice ? causes ? types ? surgical treatment
what is jaundice ? causes ? types ? surgical treatmentwhat is jaundice ? causes ? types ? surgical treatment
what is jaundice ? causes ? types ? surgical treatment
 
TUMORS OF LOWER URINARY TRACT
TUMORS OF LOWER URINARY TRACT TUMORS OF LOWER URINARY TRACT
TUMORS OF LOWER URINARY TRACT
 
Pancretitis
PancretitisPancretitis
Pancretitis
 
GI Bleeding (Upper and Lower GIB)
GI Bleeding (Upper and Lower GIB)GI Bleeding (Upper and Lower GIB)
GI Bleeding (Upper and Lower GIB)
 
Rectal prolapse
Rectal prolapseRectal prolapse
Rectal prolapse
 
Immunological mechanism of kidney injury
Immunological mechanism of kidney injuryImmunological mechanism of kidney injury
Immunological mechanism of kidney injury
 
Achalasia
AchalasiaAchalasia
Achalasia
 
Appendicitis
AppendicitisAppendicitis
Appendicitis
 

Similar to Approach to infectious disease.pptx

infections-after-transplantation.ppt
infections-after-transplantation.pptinfections-after-transplantation.ppt
infections-after-transplantation.ppt
Samafalechannel
 
Idsa guidelines
Idsa guidelinesIdsa guidelines
Idsa guidelines
Deepika Malik
 
Tissue culture waste disposal guide
Tissue culture waste disposal guideTissue culture waste disposal guide
Tissue culture waste disposal guide
Tassanee Lerksuthirat
 
Immunopatologi Sepsis
Immunopatologi SepsisImmunopatologi Sepsis
Immunopatologi Sepsis
DoroteaNina1
 
Neutropenia rcnt.pptx
Neutropenia rcnt.pptxNeutropenia rcnt.pptx
Neutropenia rcnt.pptx
RashmitaDahal
 
Hepatitis C presentation
Hepatitis C presentation Hepatitis C presentation
Hepatitis C presentation
Amr Eldakroury
 
Febrile neutropenia
Febrile neutropeniaFebrile neutropenia
Febrile neutropenia
Ahmed Allam
 
Lec 1. introduction to infectious disease
Lec 1. introduction to infectious diseaseLec 1. introduction to infectious disease
Lec 1. introduction to infectious disease
Ayub Abdi
 
AIDS and HIV.pptx
AIDS and HIV.pptxAIDS and HIV.pptx
AIDS and HIV.pptx
Pradeep Pande
 
Febrile neutropenia
Febrile neutropeniaFebrile neutropenia
Febrile neutropenia
ajayyadav753
 
Donor infective status and potential impact on recipients
Donor infective status and potential impact on recipientsDonor infective status and potential impact on recipients
Donor infective status and potential impact on recipients
Dino Sgarabotto
 
Febrile Neutropenia.pptx , low neutrophil with fever
Febrile Neutropenia.pptx , low neutrophil with feverFebrile Neutropenia.pptx , low neutrophil with fever
Febrile Neutropenia.pptx , low neutrophil with fever
sengsong07072000
 
Bioterrorism and emerging infectious disease
Bioterrorism  and emerging infectious diseaseBioterrorism  and emerging infectious disease
Bioterrorism and emerging infectious disease
Sindhuja Yella
 
Supportive care in haemato oncology
Supportive  care in  haemato oncologySupportive  care in  haemato oncology
Supportive care in haemato oncology
Habibah Chaudhary
 
Uritericial vascuilitis is still a mystery .pptx
Uritericial vascuilitis is still a mystery .pptxUritericial vascuilitis is still a mystery .pptx
Uritericial vascuilitis is still a mystery .pptx
Marwa Besar
 
Lab Investigations.pptx
Lab Investigations.pptxLab Investigations.pptx
Lab Investigations.pptx
Nneka igboeli
 
Infectious diseases
Infectious diseasesInfectious diseases
Infectious diseases
ERIC GENERAL
 
Dengue
DengueDengue
viral infection after organ transplantation
 viral infection after organ transplantation viral infection after organ transplantation
viral infection after organ transplantation
Peshraw Gawany
 
Neutropenia.pptx management , nursing management, patient education
Neutropenia.pptx management , nursing management, patient educationNeutropenia.pptx management , nursing management, patient education
Neutropenia.pptx management , nursing management, patient education
RashmitaDahal
 

Similar to Approach to infectious disease.pptx (20)

infections-after-transplantation.ppt
infections-after-transplantation.pptinfections-after-transplantation.ppt
infections-after-transplantation.ppt
 
Idsa guidelines
Idsa guidelinesIdsa guidelines
Idsa guidelines
 
Tissue culture waste disposal guide
Tissue culture waste disposal guideTissue culture waste disposal guide
Tissue culture waste disposal guide
 
Immunopatologi Sepsis
Immunopatologi SepsisImmunopatologi Sepsis
Immunopatologi Sepsis
 
Neutropenia rcnt.pptx
Neutropenia rcnt.pptxNeutropenia rcnt.pptx
Neutropenia rcnt.pptx
 
Hepatitis C presentation
Hepatitis C presentation Hepatitis C presentation
Hepatitis C presentation
 
Febrile neutropenia
Febrile neutropeniaFebrile neutropenia
Febrile neutropenia
 
Lec 1. introduction to infectious disease
Lec 1. introduction to infectious diseaseLec 1. introduction to infectious disease
Lec 1. introduction to infectious disease
 
AIDS and HIV.pptx
AIDS and HIV.pptxAIDS and HIV.pptx
AIDS and HIV.pptx
 
Febrile neutropenia
Febrile neutropeniaFebrile neutropenia
Febrile neutropenia
 
Donor infective status and potential impact on recipients
Donor infective status and potential impact on recipientsDonor infective status and potential impact on recipients
Donor infective status and potential impact on recipients
 
Febrile Neutropenia.pptx , low neutrophil with fever
Febrile Neutropenia.pptx , low neutrophil with feverFebrile Neutropenia.pptx , low neutrophil with fever
Febrile Neutropenia.pptx , low neutrophil with fever
 
Bioterrorism and emerging infectious disease
Bioterrorism  and emerging infectious diseaseBioterrorism  and emerging infectious disease
Bioterrorism and emerging infectious disease
 
Supportive care in haemato oncology
Supportive  care in  haemato oncologySupportive  care in  haemato oncology
Supportive care in haemato oncology
 
Uritericial vascuilitis is still a mystery .pptx
Uritericial vascuilitis is still a mystery .pptxUritericial vascuilitis is still a mystery .pptx
Uritericial vascuilitis is still a mystery .pptx
 
Lab Investigations.pptx
Lab Investigations.pptxLab Investigations.pptx
Lab Investigations.pptx
 
Infectious diseases
Infectious diseasesInfectious diseases
Infectious diseases
 
Dengue
DengueDengue
Dengue
 
viral infection after organ transplantation
 viral infection after organ transplantation viral infection after organ transplantation
viral infection after organ transplantation
 
Neutropenia.pptx management , nursing management, patient education
Neutropenia.pptx management , nursing management, patient educationNeutropenia.pptx management , nursing management, patient education
Neutropenia.pptx management , nursing management, patient education
 

Recently uploaded

CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
DRPREETHIJAMESP
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 

Approach to infectious disease.pptx

  • 1. Approach to the Patient with an Infectious Disease Dr. Krishn Undaviya
  • 2. Infectious Disease • Annually, 15% of all deaths worldwide are directly attributable to infectious diseases. • Infectious diseases remain the second leading cause of death worldwide. • Although the rate of infectious disease–related deaths has decreased dramatically over the past 25 years .
  • 3. WHEN TO OBTAIN AN INFECTIOUS DISEASE CONSULT • Specific situations that might prompt a consult include • (1) difficult-to-diagnose patients with presumed infections, • (2) patients who are not responding to treatment as expected, • (3) patients with a complicated medical history (e.g., organ transplant recipients, patients immunosuppressed due to auto- immune or inflammatory conditions), and • (4) patients with “exotic” diseases (i.e., diseases that are not typically seen within the region).
  • 4. History 1. Exposure History 2. Social History 3. Dietary habits 4. Animal exposure 5. Travel history 6. Host specific factors • These aspects focus on two areas: • (1) an exposure history that may identify microorganisms with which the patient may have come into contact and • (2) host-specific factors that may predispose to the development of an infection.
  • 5. Exposure History • History of infections or exposure to drug-resistant microbes • Whether a patient has a history of infection with drug- resistant organisms (e.g., methicillin- resistant S. aureus, vancomycin- resistant Enterococcus species, enteric organisms that produce an extended-spectrum β-lactamase or carbapenemase) or • May have been exposed to drug-resistant microbes (e.g., during a recent stay in a hospital, nursing home, or long-term acute-care facility) may alter the choice of empirical antibiotics. • For example, a patient presenting with sepsis who is known to have a history of invasive infection with a multidrug-resistant isolate of P. aeruginosa should be treated empirically with an antimicrobial regimen that will cover this strain. (penicillin or Cephalosporin)
  • 6. Social History • High- risk behaviors (e.g., unsafe sexual behaviors, intravenous [IV] drug use) • Potential hobby-associated exposures (e.g., avid gardening, with possible Sporothrix schenckii exposure) • Occupational exposures (e.g., increased risk for M. tuberculosis exposure in funeral service workers)
  • 7. Dietary habits • Shiga toxin–producing strains of Escherichia coli, and Toxoplasma gondii are associated with the consumption of raw or undercooked meat • Salmonella typhimurium, Listeria monocytogenes, and Mycobacterium bovis with unpasteurized milk • Leptospira species, parasites, and enteric bacteria with unpurified water • Vibrio species, norovirus, helminths, and protozoa with raw seafood.
  • 8. Animal exposure • Dogs: Lyme disease, Rocky Mountain spotted fever, and ehrlichiosis • Cats: Bartonella henselae infection • Reptiles: Salmonella infection • Rodents: leptospirosis • Rabbits: tularemia
  • 9. Travel history • H/o international or domestic travel • What kinds of activities and behaviors the patient engaged in during travel (e.g., the types of food and sources of water consumed, freshwater swimming, animal exposures) • Whether the patient had the necessary immunizations and/or took the necessary prophylactic medications prior to travel;
  • 10. Host specific factors • Many opportunistic infections (e.g., with Pneumocystis jirovecii, Aspergillus species, or JC virus) affect primarily immunocompromised patients • Defects in the immune system may be due to: • an underlying disease (e.g., malignancy, HIV infection, malnutrition), • a medication (e.g., chemotherapy, glucocorticoids, monoclonal antibodies to components of the immune system), • a treatment modality (e.g., total body irradiation, splenectomy), • or a primary immunodeficiency.
  • 11. General Examination • Vital signs • Lymphatics • Wbc count • Inflammatory marker • CSF • Skin • Culture • Radiology
  • 12. Vital signs • Elevations in temperature are often a hallmark of infection • Paying close attention to the temperature may be of value in diagnosing an infectious disease. • For every 1°C (1.8°F) increase in core temperature, the heart rate typically rises by 15–20 beats/min. • Although this pulse–temperature dissociation is not highly sensitive or specific for establishing a diagnosis, it is potentially useful in low-resource settings given its ready availability and simplicity.
  • 13.
  • 14. Skin • It is important to perform a complete skin exam, with attention to both front and back. • In numerous anecdotal instances, patients in the intensive care unit have had “fever of unknown origin” that was actually due to unrecognized pressure ulcers. • Moreover, close examination of the distal extremities for splinter hemorrhages, Janeway lesions, or Osler’s nodes may yield evidence of endocarditis or other causes of septic emboli.
  • 15. Foreign Body • As previously mentioned, many infections are caused by members of the indigenous microbiota. • These infections typically occur when these microbes escape their normal habitat and enter a new one. • Thus, maintenance of epithelial barriers is one of the most important mechanisms in protection against infection. • However, hospitalization of patients is often associated with breaches of these barriers—e.g., due to placement of IV lines, surgical drains, or tubes (e.g., endotracheal tubes and Foley cathe- ters) that allow microorganisms to localize in sites to which they normally would not have access • Accordingly, knowing what lines, tubes, and drains are in place is helpful in ascertaining what body sites might be infected.
  • 16. Diagnostic Testing • Laboratory and radiologic testing has advanced greatly over the past few decades and has become an important component in the evaluation of patients. • The dramatic increase in the number of serologic diagnostics, antigen tests, and molecular diagnostics available to the physician has, in fact, revolutionized medical care. • However, all of these tests should be viewed as adjuncts to the history and physical examination—not a replacement for them.
  • 17. WBC Count • Elevations in the WBC count are often associated with infection, • though many viral infections are associated with leukopenia. Like influenza, HIV, hepatitis, autoimmune conditions like RA, lupus, Sjogren, Hodgkins lymphoma, Myelofibrosis. • it is important to assess the WBC differential, given that different classes of microbes are associated with various leukocyte types : • Bacteria: polymorphonuclear neutrophils • Virus: lymphocytes • Parasites: eosinophills
  • 18. Inflammatory marker • ESR & CRP • ESR: Indirect measure of acute phase response • CRP: Direct measure of acute phase response • used to assess a patient’s general level of inflammation. • ESR changes relatively slowly, and its measurement more often than weekly usually is not useful; in contrast, CRP concentrations change rapidly, and daily measurements can be useful in the appropriate context. • An extremely elevated ESR (>100 mm/h) has a 90% predictive value for a serious underlying disease
  • 19.
  • 20. CSF • Assessment of CSF is critical for patients with suspected meningitis or encephalitis. • An opening pressure should always be recorded, and fluid should routinely be sent for cell counts, Gram’s stain and culture, and determination of glucose and protein levels. • A CSF Gram’s stain typically requires >105 bacteria/mL for reliable positivity; its specificity approaches 100%.
  • 21.
  • 22. Cultures • The mainstays of infectious disease diagnosis include the culture of infected tissue (e.g., surgical specimens) or fluid (e.g., blood, urine, sputum, pus from a wound). • Samples can be sent for culture of bacteria (aerobic or anaerobic), fungi, or viruses. Ideally, specimens are collected before the administration of antimicrobial therapy • in instances where this order of events is not clinically feasible, microscopic examination of the specimen (e.g., Gram- stained or potassium hydroxide [KOH]–treated preparations) is particularly important.
  • 23. Pathogen Specific Testing • For organism that are not easily cultivable • Serology • Antigen testing • PCR testing
  • 24. Radiology • Imaging provides an important adjunct to the physical examination, allowing evaluation for lymphadenopathy in regions that are not externally accessible (e.g., mediastinum, intraabdominal sites). • Assessment of internal organs for evidence of infection, and facilitation of image-guided percutaneous sampling of deep spaces. • The choice of imaging modality (e.g., CT, MRI, ultrasound, nuclear medicine, use of contrast) is best made in consultation with a radiologist to ensure that the results will address the physician’s specific concerns.
  • 25. Treatment • We should balance the need for empirical antibiotic treatment with the patient’s clinical condition. • When clinically feasible, it is best to obtain relevant samples (e.g., blood, CSF, tissue, purulent exudate) for culture prior to the administration of antibiotics, as antibiotic treatment often makes subsequent diagnosis more difficult. • Although a general maxim for antibiotic treatment is to use a regimen with as narrow a spectrum as possible, empirical regimens are necessarily somewhat broad, given that a specific diagnosis has not yet been made. • These regimens should be narrowed as appropriate once a specific diagnosis is made.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30. • The study of infectious diseases is really a study of host–microbial interactions and represents evolution by both the host and the microbe—an endless struggle in which microbes have generally been more creative and adaptive. • Given that nearly one-fifth of deaths worldwide are still related to infectious diseases, it is clear that the war against infectious diseases has not been won. For example, a cure for HIV infection is still lacking, there have been only marginal improvements in the methods for detection and treatment of tuberculosis after more than a half century of research, new infectious disease outbreaks (e.g., viral hemorrhagic fevers, Zika, SARS-CoV-2) continue to emerge, and the threat of microbial bioterrorism remains high. • Despite numerous advances in the diagnosis, treatment, and prevention of infectious diseases, much work and research are required before anyone can confidently claim we have achieved “the virtual elimination of infectious disease.” • In reality, this goal will never be attained, given the rapid adaptability of microbes.